Nicotinic acid and laropiprant modified-release tablets for treating dyslipidaemia,
Tredaptive, extended-release nicotine acid 1.000 mg and laropiprant 20 mg (ERN/LRPT), is used for treatment of combined dyslipidemia and primary hypercholesterolemia when treatment with statins are insufficient..
Tredaptive, extended-release nicotine acid 1.000 mg and laropiprant 20 mg (ERN/LRPT), is used for treatment of combined dyslipidemia and primary hypercholesterolemia when treatment with statins are insufficient..
